Corporate News     12-Feb-25 Privi Speciality Chemicals director resigns With effect from 31 March 2025 Privi Speciality Chemicals announced that Dwarko Topandas Khilnani (DlN: 01824655) has tendered his resignation from the position of Non-Executive Independent Director of the Company, with effect from close of business hours on 31 March 2025. Previous News   Privi Speciality Chemicals consolidated net profit rises 46.38% in the September 2024 quarter  ( Results - Announcements 24-Oct-24   15:37 )   Fairchem Speciality fixes record date for scheme of arrangement and amalgamation  ( Market Beat - Reports 12-Aug-20   15:22 )   Privi Speciality Chemicals consolidated net profit declines 79.34% in the June 2023 quarter  ( Results - Announcements 03-Aug-23   17:00 )   Fairchem Speciality consolidated net profit declines 42.65% in the June 2020 quarter  ( Results - Announcements 31-Jul-20   08:07 )   Fairchem Speciality standalone net profit rises 48.39% in the December 2017 quarter  ( Results - Announcements 13-Feb-18   08:11 )   Volumes jump at ITI Ltd counter  ( Hot Pursuit - 05-May-23   11:00 )   Fairchem Speciality consolidated net profit rises 836.41% in the September 2019 quarter  ( Results - Announcements 17-Nov-19   11:02 )   Privi Speciality Chemicals consolidated net profit declines 40.18% in the December 2020 quarter  ( Results - Announcements 05-Feb-21   18:04 )   Board of Fairchem Speciality approves change in company name  ( Corporate News - 12-Aug-20   15:09 )   Adi Finechem proposal for delisting of equity shares  ( Corporate News - 14-Aug-13   16:10 )   Adi Finechem to hold board meeting  ( Corporate News - 13-Oct-16   13:34 )	Other Stories   Mercury Trade Links to conduct EGM   15-Mar-25   20:06   Galada Finance to conduct board meeting   15-Mar-25   20:06   Board of Galaxy Surfactants recommends interim dividend   15-Mar-25   16:12   Heads UP Ventures announces board meeting date   15-Mar-25   16:12   Savera Industries to conduct board meeting   15-Mar-25   16:12   Strides Pharma Science announces acquisition of Singapore-based Amexel   15-Mar-25   15:45   Mphasis allots 99,115 equity shares under ESOP   15-Mar-25   15:43   Shilpa Pharma Lifesciences' Unit-2 clear USFDA inspection   15-Mar-25   15:40   Wipro grants 9,868 RSUs under ESOP   15-Mar-25   15:39   New Delhi Television announces resignation of director   15-Mar-25   15:38
Back Top